Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/23755
Full metadata record
DC FieldValueLanguage
dc.contributor.authorReddy, PM K-
dc.contributor.authorShantanu, S-
dc.contributor.authorShewade, D G-
dc.contributor.authorRamaswamy, S-
dc.date.accessioned2013-11-19T06:09:15Z-
dc.date.available2013-11-19T06:09:15Z-
dc.date.issued2001-05-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/23755-
dc.description476-478en_US
dc.description.abstractMetoclopramide, a prokinetic drug, has been documented to produce antinociceptive response in animal models through opioid pathways. Morphine has been shown to act through ATP sensitive potassium channels ( KATP) to produce antinociceptive response. However, such a possibility has not been examined for metoclopramide. The present study investigated this using pharmacological tools. Acetic acid induced abdominal constriction assay procedure was utilized to assess antinociception. The results confirmed that metoclopramide has antinociceptive response. Glibenclamide, a KATP channel blocker, pretreatment antagonized this response. Where as, in minoxidil pretreated animals, metoclopramide elicited an enhanced antinociceptive response. Glibenclamide and minoxidil, which are known KATP channel blocker and opener respectively, interfered with metoclopramide antinociception. These finding are suggestive of a role for KATP channels in metoclopramide antinociception in mice. en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.39(05) [May 2001]en_US
dc.titleEffect of ATP sensitive potassium channel modifiers on antinociceptive effect of metoclopramideen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.39(05) [May 2001]

Files in This Item:
File Description SizeFormat 
IJEB 39(5) 476-478.pdf559.34 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.